Temozolomide in children with progressive low-grade glioma. - Wikidata - wikimedia - TriplyDB

Temozolomide in children with progressive low-grade glioma.

Temozolomide in children with progressive low-grade glioma.

http://www.wikidata.org/entity/Q33374472

about

A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study Pediatric low-grade gliomas and the need for new options for therapy: Why and how?Adult pilocytic astrocytomas: clinical features and molecular analysis Pediatric low-grade gliomas: how modern biology reshapes the clinical field.Pediatric low-grade gliomas.ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents.The use and effectiveness of temozolomide in children with central nervous system tumours: a survey from the Canadian Paediatric Brain Tumour Consortium A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study.Molecular profiling of childhood cancer: Biomarkers and novel therapies Management of optic-hypothalamic gliomas in children: still a challenging problem.Bone marrow transplantation for severe aplastic anemia secondary to temozolomide.Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study.Using different schedules of Temozolomide to treat low grade gliomas: systematic review of their efficacy and toxicity.Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas.Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.Advances in the management of low-grade gliomas.Optic pathway gliomas: a review.Pediatric cerebellar astrocytoma: a review.Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors.Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.Clinical trials in pediatric neuro-oncology: what is missing and how we can improve.Conventional chemotherapy and perspectives for molecular-based oncological treatment in pediatric hemispheric low-grade gliomas.The effect of chemotherapy on optic pathway gliomas and their sub-components: A volumetric MR analysis study.Temozolomide in relapsed pediatric brain tumors: 14 cases from a single center.A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.Nonanaplastic pleomorphic xanthoastrocytoma with meningeal dissemination presenting with bilateral visual loss.A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low-grade glioma (LGG).Pediatric Low-Grade Gliomas: Next Biologically Driven Steps.Optic Pathway Gliomas in Neurofibromatosis Type 1.Current and emerging treatment strategies for children with progressive chiasmatic-hypothalamic glioma diagnosed as infants: a web-based survey.Treatment of childhood astrocytomas with irinotecan and cisplatin.Single agent vinorelbine in pediatric patients with progressive optic pathway glioma.Stereotactic radiosurgery for pilocytic astrocytomas part 2: outcomes in pediatric patients.Stereotactic radiosurgery for pilocytic astrocytomas part 1: outcomes in adult patients.Pediatric Optic Pathway/Hypothalamic Glioma.Radiotherapy in pediatric pilocytic astrocytomas. A subgroup analysis within the prospective multicenter study HIT-LGG 1996 by the German Society of Pediatric Oncology and Hematology (GPOH).Successful treatment with a low-dose cisplatin--etoposide regimen for patients with diencephalic syndrome.Visual outcome following chemotherapy for progressive optic pathway gliomas.Optic pathway ganglioglioma with intraventricular cyst.

P2860

Q33406813-4B4F302F-28D6-4E2C-B590-804B613AB936 Q33607387-BE938ECA-BF61-4042-ADD4-A35D4315B161 Q33616609-A97FE891-3DB3-4B59-8793-56DD3D242735 Q33847771-03E84F7B-4ED3-4D56-A67E-A9607DEEB7CA Q34051368-3CC07A3F-470E-4A09-8249-12535AEEFA71 Q34287713-554E2419-06BB-4E40-9B01-A732AE0A1F40 Q34541456-5E6B317A-E1E6-4BE3-9F30-DD30608C8C6C Q35133435-74C30E7E-4350-4D1B-9E6C-AD4603640B41 Q36250783-83DFF384-DCE3-4907-97C9-F2D637CDA6CD Q37004680-146E4D4C-D5B1-431D-A1FD-338DFFE3AAC1 Q37330813-69EEEEA6-188C-4036-A374-07182799AE02 Q37492128-FF8A7072-A762-4884-BDDA-A8928D6951A6 Q37900207-B3FB5349-C221-4AB5-BC1C-A0F17FD2F671 Q38043420-0DDB7D5D-1750-46AC-91CB-6A32EE6570DF Q38074880-7A616880-D2AC-44E0-849D-9E42DFF678B0 Q38219898-4BBE25AC-8F11-473D-85D9-5CDAC451E459 Q38233447-F4842901-76F0-4580-A2B7-C682C54DF5B9 Q38583246-9B2F85DF-4B5D-4BC3-9743-F50845BD55A3 Q38661348-7B6FFEDA-CD46-405B-B80D-4687675A44C1 Q38670250-239AD59B-D53C-42EF-BC74-73C6EDAA8BB3 Q38951440-903018F6-3E90-4EBF-AFE6-E6A950DC130B Q38962187-51B994F2-43B4-4013-9D43-A48553C68BAD Q41096365-CE302B6D-99D5-4578-9269-28F5CAAC67C0 Q44596535-087E4CEA-597F-44B7-AA17-2C495085178E Q46036046-8739DC7E-611E-4F21-A135-8DD56584EA4A Q46050537-F610BBF3-5018-4931-BFDD-F80C9D59A772 Q46088442-CA953F61-22B8-4E19-8341-8C9794C806E5 Q46667195-AA73E2C1-00D5-4F26-AAA7-6E968A90CA08 Q47779215-10E94E39-39FC-4632-9C8D-10C0EA03278B Q48000336-04F14052-166B-4FB1-BA12-9046A48C14B4 Q48204130-549B7DA3-DB42-475C-BD97-D620F3C98AD1 Q48467648-32B40A91-BE01-438A-88D1-41C40F1D3D2F Q48600117-0B354656-CC2F-40E9-ABFC-D49A7E8DE335 Q48600126-2FE1742C-97E4-4AC1-A7AE-FA1E4628A7F4 Q49203220-749A230E-830D-4311-887F-792A0C89E894 Q55461552-B5958EFB-5AED-4B3F-A854-FC7774AD2964 Q55462089-DB26C2F9-3422-453D-B853-E6C929BB907E Q55463492-5F669569-A9FB-4719-A4E8-ADD8F0207FD5 Q55463924-59AE82D1-C6D7-4E38-9443-489785A9AE08

P2860

Temozolomide in children with progressive low-grade glioma.

http://www.wikidata.org/entity/Q33374472

description

2007 nî lūn-bûn

@nan

2007 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մարտին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Temozolomide in children with progressive low-grade glioma.

@ast

Temozolomide in children with progressive low-grade glioma.

@en

type

label

Temozolomide in children with progressive low-grade glioma.

@ast

Temozolomide in children with progressive low-grade glioma.

@en

prefLabel

Temozolomide in children with progressive low-grade glioma.

@ast

Temozolomide in children with progressive low-grade glioma.

@en

P1433

Q33374472-62EA53DA-3241-4B29-8599-9A0E53E63F51

P1476

Q33374472-9C9A5C6A-33B1-4ABF-9D4B-761D5A6CAC7D

P2093

Q33374472-11497C1B-89C0-4699-94BE-BEF9BD2C9DD1

Q33374472-C083CB85-A040-4AF9-83FB-37EE7A753166

Q33374472-CD589BE1-F69F-471B-8F41-72928494E793

Q33374472-D953883A-8964-4400-9205-7297D492B67B

Q33374472-EAE95689-CA4A-4ED8-9D35-A2DEA2FB5331

Q33374472-FCC03C6A-5BC6-45A6-B040-9AC80B7CD3E8

Q33374472-FEDBD59A-138A-42FA-8CA3-E36BBA4E1352

Q33374472-FFA1899D-4811-4E5B-8A59-FC006C7C08F9

P2860

Q33374472-08D1D3C5-12EB-40BE-96B9-9F2379F10057

Q33374472-0C4368B5-D62B-471C-9AE1-68E92184AB32

Q33374472-0F6C1A0E-B505-47C7-9541-19FAEC7D3B16

Q33374472-27424840-42AC-46FA-95F2-E8AD6FFE7962

Q33374472-27B401C9-D0E8-460C-8A7D-0888DC90ED25

Q33374472-2EED4ABB-C3B0-4DEC-BE49-EC2E3E49C246

Q33374472-34D86C1A-4719-4159-921C-CAE93A3D2F56

Q33374472-3AF3678A-21CD-445C-8E3C-94B81EAA3F58

Q33374472-42148B5B-5923-4C3C-B498-83EF1042BCA4

Q33374472-4CE720B4-0379-4E60-AE29-90812500649C

P304

Q33374472-4A210A9C-6309-4215-9D55-9E349C4E3E09

P31

Q33374472-6B63873E-CAE3-46F8-905A-256A46BA25A0

P356

Q33374472-7A2BC09D-B13D-46F6-9F40-CE345D0877F7

P433

Q33374472-1AB6C3AE-B242-4246-A7A5-150C350AB17E

P478

Q33374472-1123AB90-827A-4078-AC0B-AAB38846661E

P50

Q33374472-3ED752E2-C1B9-489B-A161-48A1E2022E4A

Q33374472-79181E14-620E-4557-A702-5EB815B43706

Q33374472-93D402E4-A356-434D-B959-79DC164CE6A8

Q33374472-AEDD8D7C-4335-47DA-85FB-4E671D84DD47

Q33374472-D5310D25-BAE0-4981-8DF2-F3A494316DEB

P577

Q33374472-1C19DD04-9E83-4EC9-9127-0ED2B197DD0A

P5875

Q33374472-C40A3050-770B-4E3B-A7C1-0C7CD91A9416

P698

Q33374472-6D4DC607-3864-4FB7-8E0A-0B67C66CB56E

P932

Q33374472-8C726C03-4384-405D-A2B7-A780DCBA491A

P356

15228517-2006-030

P1433

P1476

Temozolomide in children with progressive low-grade glioma.

@en

P2093

James E Herndon

http://www.w3.org/2001/XMLSchema#string

James J Vredenburgh

http://www.w3.org/2001/XMLSchema#string

Jeanne M Krauser

http://www.w3.org/2001/XMLSchema#string

Jeffrey C Allen

http://www.w3.org/2001/XMLSchema#string

Jennifer A Quinn

http://www.w3.org/2001/XMLSchema#string

Melody A Watral

http://www.w3.org/2001/XMLSchema#string

Michael J Fisher

http://www.w3.org/2001/XMLSchema#string

Peter C Phillips

http://www.w3.org/2001/XMLSchema#string

P2860

Considerations on the role of chemotherapy and modern radiotherapy in the treatment of childhood low grade glioma.

Multidisciplinary management of pediatric low-grade gliomas.

Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions.

Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies

Phase II study of carboplatin in children with progressive low-grade gliomas.

Phase II trial of temozolomide in patients with progressive low-grade glioma.

Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules

Temozolomide is active in childhood, progressive, unresectable, low-grade gliomas.

Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen.

Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children's Cancer Group.

P304

161-168

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1215/15228517-2006-030

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Henry Seth Friedman

Annick Desjardins

Sridharan Gururangan

David A Reardon

P577

2007-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6460411

http://www.w3.org/2001/XMLSchema#string

P698

17347491

http://www.w3.org/2001/XMLSchema#string

P932

1871667

http://www.w3.org/2001/XMLSchema#string